84
Participants
Start Date
April 30, 2016
Primary Completion Date
December 31, 2017
Study Completion Date
January 31, 2018
Spiromax (budesonide/formoterol)
"DuoResp Spiromax 160 (160 micrograms budesonide/4.5 micrograms formoterol fumarate dihydrate), either one inhalation twice a day (morning and evening) or two inhalations twice a day (morning and evening), for 1 week.~Additional 8 weeks in one subgroup"
Turbohaler (budesonide/formoterol)
Turbohaler® (160 micrograms budesonide/4.5 micrograms formoterol fumarate dihydrate)- Symbicort® 160/4.5. Dose of one inhalation twice a day (mornig and evening) or two inhalations twice a day (morning and evening), for 1 week. Additional 8 weeks in one subgroup
Diskus(50mcg salmeterol &250/500 mcg fluticasone propionate)
Diskus® inhaler(50mcg salmeterol\&250/500mcg fluticasone propionate)-Seretide Diskus 50/250mcg® or 50/500mcg.Dose of 1inhalation twice a day for1 week.Additional 8 weeks in1subgroup
4) Clinica di Malattie dall'Apparato Respiratorio Fondazione Salvatore Maugeri, Tradate
University Hospital S Anna, Ferrara
3) Fondazione S. Maugeri - IRCCS - Dipartimento di Pneumologia Riabilitativa, Cassano delle Murge
Consorzio Futuro in Ricerca
OTHER